Skip to main content

Type 1 diabetes, devices and technology


05-18-2020 | Type 1 diabetes | News

Characteristics of adult- versus childhood-onset type 1 diabetes documented

Age at type 1 diabetes diagnosis does not appear to affect glycemic control and comorbidity once disease is established, but important differences occur between age groups at the time of diagnosis, US study data show.

05-14-2020 | COVID-19 | News

Glycemic control improved in type 1 diabetes under Italian lockdown

Italian researchers report that the slower pace of life forced on people with type 1 diabetes during lockdown amid the COVID-19 outbreak resulted in improved glycemic control.

04-21-2020 | Adolescents | News

Cost, hassle, and technology anxiety prevent adolescents using diabetes devices

A survey of US adolescents with type 1 diabetes has found that cost, negative attitudes towards wearing a device, and technology-related anxiety all act as obstacles preventing the use of devices in this age group.

02-20-2020 | Mobile technology | News

Mobile access to online self-management tools may improve diabetes care

People with diabetes who access an online self-management portal through mobile devices have better medication adherence and glycemic control than those with computer-only or no access to the portal, researchers report.

02-18-2020 | Flash glucose monitoring | News

Flash glucose monitor performs adequately throughout its lifetime

Study results suggest that the accuracy of the FreeStyle Libre 14-day flash glucose monitoring system is adequate for patients with type 1 diabetes during its entire lifetime, although it tends to be less so during the beginning and end of its use.

02-12-2020 | Flash glucose monitoring | News

Flash monitoring confirms safety cushion of preserved C-peptide

Even minimal residual C-peptide secretion protects people with type 1 diabetes from hypoglycemic events, and reduces glycemic variability, show data from flash glucose monitoring.

02-10-2020 | Artificial pancreas systems | News

Greatest beneficiaries of closed-loop systems not always as HCPs assume

Healthcare professionals can make false assumptions about which children with type 1 diabetes will gain most from closed-loop insulin delivery, risking children who could potentially benefit missing out, research suggests.

01-29-2020 | Artificial pancreas systems | News

Rapid insulin–pramlintide artificial pancreas improves glycemic control in type 1 diabetes

A novel artificial pancreas that delivers both rapid insulin and pramlintide improves glycemic control compared with one that delivers rapid insulin alone, without increasing hypoglycemia rates, in people with type 1 diabetes, Canadian research shows.

01-21-2020 | Artificial pancreas systems | News

Phone-controlled closed-loop insulin delivery an ‘appealing alternative’

A randomized trial shows the feasibility of closed-loop insulin delivery controlled by an algorithm on a user’s phone rather than in their pump, but also highlights issues with connectivity.

01-10-2020 | Flash glucose monitoring | News

Long-term flash monitoring use may reduce work absences

People with type 1 diabetes remain broadly satisfied with flash glucose monitoring in the long term and its use may reduce acute diabetes complications and work absences, real-world data suggest.

01-07-2020 | Insulin pumps | Highlight | News

Insulin pumps may help stabilize glucose levels over the long term

Continuous subcutaneous insulin infusion users have more stable glycated hemoglobin levels over the long term than multiple daily injection users with type 1 diabetes, a real-world study suggests.

11-22-2019 | Liraglutide (obesity) | News

Add-on liraglutide benefits overweight insulin pump users with poor glycemic control

Adding liraglutide to continuous subcutaneous insulin infusion significantly reduces glycated hemoglobin without increasing hypoglycemia in overweight and obese people with type 1 diabetes and suboptimal glycemic control, Danish research shows.

11-05-2019 | Pregnancy | News

Breastfeeding study informs on insulin pump settings after childbirth

A small Danish study in breastfeeding women with long-term type 1 diabetes could provide useful information on which insulin pump settings to use after childbirth.

10-16-2019 | Artificial pancreas systems | News

iDCL trial shows sustained time in range improvement with hybrid closed-loop delivery

People with type 1 diabetes using the Tandem Control-IQ hybrid closed-loop insulin delivery system spent significantly more time within their target blood glucose range than people using a sensor-augmented insulin pump during 6 months of use in the iDCL trial.

09-25-2019 | Hypoglycemia | EASD 2019 | News

Daytime hyperglycemia, nocturnal hypoglycemia remain problems for EDIC cohort

People with type 1 diabetes rarely achieve the current targets for blood glucose control, with nocturnal hypoglycemia remaining a particular concern, shows an analysis of the DCCT/EDIC cohort.

09-19-2019 | Continuous glucose monitoring | EASD 2019 | News

Majority of MDI users improve glycemic outcomes with CGM

Analysis of the GOLD study suggests that at least three-quarters of people with type 1 diabetes using multiple daily injections benefit from continuous glucose monitoring.

09-17-2019 | Continuous glucose monitoring | EASD 2019 | News

CGM benefits persist with long-term use

The COMISAIR-2 researchers have reported that use of continuous glucose monitoring by people with type 1 diabetes remains high over 3 years, resulting in continued glycemic benefits.

08-27-2019 | Insulin pumps | News

Predictive low-glucose insulin suspend system cuts hypoglycemia in real world

Switching to a predictive low-glucose suspend insulin delivery system significantly reduces hypoglycemia risk in people with diabetes in clinical practice, research shows.

08-08-2019 | Continuous glucose monitoring | News

Pros and cons of CGM described by parents of children with diabetes

Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.

07-23-2019 | Artificial pancreas systems | News

Medtronic closed-loop system with bolus correction promising in first clinical trial

The latest iteration to the Medtronic artificial pancreas system, which includes automated correction boluses, shows promising results in its first home-based trial.

Image Credits